Madison Park Capital Advisors, LLC Gilead Sciences, Inc. Transaction History
Madison Park Capital Advisors, LLC
- $123 Billion
- Q4 2025
A detailed history of Madison Park Capital Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Madison Park Capital Advisors, LLC holds 1,930 shares of GILD stock, worth $239,493. This represents 0.19% of its overall portfolio holdings.
Number of Shares
1,930
Previous 1,997
3.36%
Holding current value
$239,493
Previous $222 Million
6.87%
% of portfolio
0.19%
Previous 0.18%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
2,399Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...